Question 1

What is Reviva Pharmaceuticals Holdings?

Accepted Answer

Reviva Pharmaceuticals Holdings is a Company.

Question 2

How often does Reviva Pharmaceuticals Holdings appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Reviva Pharmaceuticals Holdings first tracked by NewsDesk?

Accepted Answer

First tracked on May 13, 2026.

Question 4

When was Reviva Pharmaceuticals Holdings last mentioned in news?

Accepted Answer

Last active on May 13, 2026.

Question 5

What is Reviva Pharmaceuticals Holdings's current news sentiment?

Accepted Answer

Aggregate sentiment score: 20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Reviva Pharmaceuticals Holdings in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Reviva Pharmaceuticals Holdings?

Accepted Answer

Reviva Q1 Earnings, Patent, Nasdaq Delisting (May 13, 2026, 6 articles).

Question 8

How did the "Reviva Q1 Earnings, Patent, Nasdaq Delisting" event impact Reviva Pharmaceuticals Holdings?

Accepted Answer

Reviva Pharmaceuticals Holdings reported its Q1 2026 financial results, including a reduced net loss and increased cash, and provided updates on its brilaroxazine development program, including a new patent application and upcoming Phase 3 trial. Its stock will transition from Nasdaq-100 to OTCQB Venture Market.

Question 9

How is this data collected?

Accepted Answer

NewsDesk aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.